Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 5Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 11INDUSTRY 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Lung Neoplasms 1Esophageal Squamous Cell Neoplasia (ESCN) 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Radiofrequency Ablation × Clear all
NCT03621319 2021-07-06

BURN

Erbe Elektromedizin GmbH

Phase NA Terminated
41 enrolled
Gastrointestinal

Barrett Esophagus

NCT02953418 2020-08-12

REACH

Medtronic - MITG

Phase NA Terminated
34 enrolled 11 charts
Gastrointestinal

Esophageal Squamous Cell Neoplasia (ESCN)

NCT03272971 2019-11-01

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Broncus Medical Inc

Phase NA Terminated
3 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡